Quantification of methylphenidate in rat, rabbit and dog plasma using a chiral liquid-chromatography/tandem mass spectrometry method
luis ramos
Analytica Chimica Acta, 2002
View PDFchevron_right
Simultaneous detection of methylphenidate and its main metabolite, ritalinic acid, in doping control
Jordi Segura
Journal of chromatography. B, Biomedical applications, 1994
View PDFchevron_right
Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography–tandem mass spectrometry, gas chromatography–mass spectrometry, and immunoassay methods
Michele Etter
Clinical Biochemistry, 2004
View PDFchevron_right
Liquid-chromatographic analysis for methylphenidate (Ritalin) in serum
James Swanson
Clinical chemistry, 1979
View PDFchevron_right
Methylphenidate: Its Pharmacology and Uses
Thomas Challman
Mayo Clinic Proceedings, 2000
View PDFchevron_right
Methylphenidate: A Review
suzana vasconcelos
2021
View PDFchevron_right
The plasma level of methylphenidate in the single-dose oral methylphenidate test
Frederik A de Wolff, Jaap Goekoop
Biological Psychiatry, 1990
View PDFchevron_right
Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate
Amy Harms
CPT: Pharmacometrics & Systems Pharmacology
View PDFchevron_right
Correlation Between Methylphenidate and Ritalinic Acid Concentrations in Oral Fluid and Plasma
Oscar Garcia Algar
Clinical Chemistry, 2010
View PDFchevron_right
Methylphenidate - Appraisement of Clinical Indications and Contraindications
Mirto Prandini
Medical journal of clinical trials & case studies, 2020
View PDFchevron_right
P.7.c.005 Pharmacokinetics, detection, likeability and dislikeability of two formulations of long-acting oral methylphenidate
Bertha Madras
European Neuropsychopharmacology, 2006
View PDFchevron_right
Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject
Óscar García-algar
Forensic Science International, 2010
View PDFchevron_right
Toxicokinetic assessment of methylphenidate(Ritalin®) in a 13-week oral toxicity study in dogs
luis ramos
Biomedical Chromatography, 2004
View PDFchevron_right
Simultaneous Determination of Methylphenidate, Amphetamine and their Metabolites in Urine using Direct Injection Liquid Chromatography-Tandem Mass Spectrometry
SUNGILL SUH
Mass Spectrometry Letters
View PDFchevron_right
{"__content__"=>" Neurochemical Assessment of Methylphenidate and Its \"Legal High\" Analogs 3,4-CTMP and Ethylphenidate in Rat Nucleus Accumbens and Bed Nucleus of the Stria Terminalis.", "i"=>{"__content__"=>"In Vitro"}}
John Ramsey
Frontiers in psychiatry, 2018
View PDFchevron_right
Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates
Christopher Ruark, Merle Paule
PloS one, 2014
View PDFchevron_right
Methylphenidate: Increased Abuse or Appropriate Use ?
M. Crismon
Journal of the American Pharmaceutical Association (1996), 1999
View PDFchevron_right
Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans
Declan Quinn
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1991
View PDFchevron_right
Pharmacokinetics of methylphenidate following two oral formulations (immediate and sustained release) in the dog
Mario Giorgi
Veterinary Research Communications, 2010
View PDFchevron_right
Study of the safety of methylphenidate: Focus on nephrotoxicity aspects
Dânya Lima
View PDFchevron_right
Quantitative determination of methylphenidate in plasma by gas chromatography negative ion chemical ionisation mass spectrometry using o-(pentafluorobenzyloxycarbonyl)-benzoyl derivatives
Hans Leis
Analytical and Bioanalytical Chemistry, 2011
View PDFchevron_right
Negative ion chemical ionization for the determination of methylphenidate in human plasma by stable isotope dilution gas chromatography/mass spectrometry
Günther Raspotnig
Journal of Mass Spectrometry, 2000
View PDFchevron_right
A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior
David Komatsu
Pharmacology Biochemistry and Behavior, 2015
View PDFchevron_right
High-throughput selected reaction monitoring liquid chromatography–mass spectrometry determination of methylphenidate and its major metabolite, ritalinic acid, in rat plasma employing monolithic columns
Jack Henion
Journal of Chromatography B, 2003
View PDFchevron_right
Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 mice
Donald Mattison
Environmental and Molecular Mutagenesis, 2008
View PDFchevron_right
Methylphenidate Has Positive Hypocholesterolemic and Hypotriglyceridemic Effects: New Data
Alexander Rabinovich, Gideon Charach
The Journal of Clinical Pharmacology, 2009
View PDFchevron_right
Assessment of Methylphenidate Prescriptions Written for the Treatment of Attention-Deficit/Hyperactivity Disorder
ibrahim topçu
View PDFchevron_right
Non-medical use of methylphenidate: a review
Helena Barros
Trends in Psychiatry and Psychotherapy, 2012
View PDFchevron_right
Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data
James Swanson
BMC psychiatry, 2004
View PDFchevron_right